International Isotopes
This article was originally published in The Gray Sheet
Executive Summary
Firm's IsoStar I-125 brachytherapy seeds will be launched by Imagyn Medical Technologies in the fourth quarter of 1998. Under a deal inked by the firms in January, Imagyn has exclusive worldwide marketing rights to the 510(k)-cleared radioactive seeds used in the treatment of tumors ("The Gray Sheet" Jan. 26, In Brief)